Curate Biosciences

Transformative Cell Processing for Next-Generation Therapies

At Curate Biosciences we see a future where patients, clinicians, innovators, and payors routinely embrace cell and gene therapies against intractable disease. We foresee a world in which life-saving therapies are readily accessible to all, earlier in the treatment protocol, with longer persistence, fewer side effects, and with a positive impact to healthcare economics.

To help make this future a reality, we focus on advancing our platform technology, Deterministic Cell Separation™, to deliver greater quantities of the highest quality cellular starting materials, faster and less costly, to the innovators, developers, and clinicians pushing the boundaries of the possible.

Our Team

Mike Grisham
Mike Grisham

Chief Executive Officer

Tony Ward
Tony Ward

Chief Technology Officer

Jason Walsh
Jason Walsh

Chief Financial Officer

Gaurav Vij
Gaurav Vij

Chief Business Officer

Joan Haab
Joan Haab

Senior Vice President, Manufacturing and Supply Chain

Khushroo Gandhi
Khushroo Gandhi

Vice President, Product Development and Manufacturing

Roberto Campos-González
Roberto Campos-González

Vice President, Biology

Alison Skelley
Alison Skelley

Senior Director, Engineering and IP Strategy

Deepa Patel
Deepa Patel

Director of Finance and Administration

Cole Jones
Cole Jones

Marketing Manager

Yasna Behmardi
Yasna Behmardi

Senior Microfluidics Engineer

Laurissa Ouaguia
Laurissa Ouaguia

Staff Scientist

Rechea Christie
Rechea Christie

Quality Engineer

Scientific Advisory Board

Curt Civin, MD – Chairman

  • University of Maryland School of Medicine – Professor of Pediatrics & Physiology, Director of Center for Stem Cell Biology & Regenerative Medicine, Associate Dean for Research
  • Previously, 30+ years endowed Professor at Johns Hopkins School of Medicine
  • Discovered CD34 stem antigen and Mab, expert in stem cell biology, leukemia, and cellular analysis
  • Amherst College, ScD Hon 2001; Harvard Medical School, MD 1974; Amherst College, BA 1970

James Sturm, PhD

  • Director, Princeton Institute for the Science and Technology of Materials, William and Edna Macaleer Professor of Engineering and Applied Science, Professor of Electrical Engineering, Princeton University

Harry Malech, MD

  • Chief, Genetic Immunotherapy Section, NIH/NIAID

Michael Meagher, MD

  • Vice President, Therapeutics Production and Quality, St. Jude’s Childrens Research Hospital

Djordje Atanackovic, MD

  • Medical Director of the Fannie Angelos Cellular Therapeutics Laboratory and Director of Cellular and Vaccine Immunotherapy, University of Maryland School of Medicine Marlene & Stewart Greenebaum Comprehensive Cancer Center

Nancy Hardy, MD

  • Medical Director, Cell Therapy & Graft Engineering; Associate Director, Blood & Marrow Transplantation Program; Medical Director for Cancer Center Quality & Safety – University of Maryland School of Medicine Marlene & Stewart Greenebaum Comprehensive Cancer Center

Philip Tagari

  • Vice President, Research, Amgen Inc.